ArticleFrontiers in oncology2026
False-positive cervical lymph nodes on FAPI PET/CT after neoadjuvant chemotherapy for breast cancer: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 49-year-old woman with cT3N1M0 stage IIIA HER2-positive invasive breast cancer is described in this retrospective case report. After six cycles of TCHP neoadjuvant chemotherapy, breast MRI confirmed that the primary lesion and axillary lymph nodes achieved radiological complete response. However, newly enlarged lymph nodes in levels II and III of the left neck were detected by neck ultrasound and contrast-enhanced CT. Subsequent 18F-FAPI-04 PET/CT revealed significantly elevated tracer uptake in these cervical lymph nodes, with a maximum standardized uptake value (SUVmax) of 18.2, which was highly suspicious for metastasis. Ultrasound-guided core needle biopsy and postoperative histopathological examination finally confirmed that these cervical lymph nodes were benign reactive lymphoid hyperplasia with focal necrosis and inflammatory cell infiltration, and the patient achieved pathological complete response in both breast and axillary regions without any lymph node metastasis. This case reveals that despite the high sensitivity of FAPI PET/CT in detecting malignant tumor lesions, benign post-treatment inflammatory processes can induce significant FAP upregulation, leading to typical false-positive results. Clinical interpretation of FAPI PET/CT findings must be closely integrated with the patient's treatment history and multimodality examinations, and histopathology should remain the gold standard for definitive lesion characterization to avoid unnecessary misdiagnosis and overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.